Syros Pharmaceuticals Inc(SYRS) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in a Phase II clinical trial for genomically defined subset of patients with acute myeloid leukemia and myelodysplastic syndrome; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts.

Current Price

$5.20

RSI

13.589

Beta:

1.903412

March 04, 2021
66.2M
-30M

669.094 %
141.767 %
-52.719 %
-6.559 %

$13,301,000
$1,982,000
$2,050,000
$1,101,000
$317,000
571.090 %
-3.431 %
86.194 %
247.319 %

$-84,034,000
$-75,410,000
$-62,255,000
$-54,003,000
$-66,243,000
-10.263 %
-17.445 %
-13.255 %
22.665 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.